NEUE PHARMAZEUTISCHE VERWENDUNG

Patent europeic · EP4570314 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4570314
Numer da la dumonda
EP25173384
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
09-05-2016
Publitgà
18-06-2025
Concedì
15-07-2026
La protecziun finescha il pli tard
08-05-2036
Proxima taxa annuala scadenta
31-05-2027
Classas IPC
A61K 31/225 (2006.01)
A61K 31/41 (2006.01)
A61P 9/04 (2006.01)
Prioritad
US 201562159703 P 11.05.2015
Derivà da
EP23154757
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 16-07-2026

    Represchentant inscrit

    Representative
    E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 16.07.2026

  2. 15-07-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 15.07.2026

Partidas

Possessur

Novartis AG

Lichtstrasse 35, 4056 Basel

Represchentant

E. Blum & Co. AG

Hofwiesenstrasse 349, 8050 Zürich

Inventur

RIZKALA, Adel Redmond

East Hanover, 07936, US

SHI, Victor Chengwei

East Hanover, 07936, US

CHEN, Fabian

East Hanover, 07936, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.